Church & Dwight Co., Inc. (NYSE:CHD) Stake Lowered by Xponance Inc.

Xponance Inc. cut its stake in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 0.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 33,380 shares of the company’s stock after selling 167 shares during the quarter. Xponance Inc.’s holdings in Church & Dwight were worth $3,495,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Board of the Pension Protection Fund bought a new position in shares of Church & Dwight during the fourth quarter valued at approximately $639,000. Oddo BHF Asset Management Sas bought a new position in shares of Church & Dwight during the third quarter valued at approximately $5,934,000. Citigroup Inc. grew its holdings in shares of Church & Dwight by 9.1% during the third quarter. Citigroup Inc. now owns 337,738 shares of the company’s stock valued at $35,368,000 after purchasing an additional 28,129 shares during the last quarter. Financial Enhancement Group LLC boosted its position in shares of Church & Dwight by 456.2% during the fourth quarter. Financial Enhancement Group LLC now owns 60,585 shares of the company’s stock worth $6,232,000 after buying an additional 49,693 shares during the period. Finally, Merit Financial Group LLC boosted its position in shares of Church & Dwight by 131.0% during the fourth quarter. Merit Financial Group LLC now owns 5,769 shares of the company’s stock worth $604,000 after buying an additional 3,272 shares during the period. 86.60% of the stock is owned by institutional investors.

Insider Buying and Selling at Church & Dwight

In other news, EVP Rene Hemsey sold 11,060 shares of the company’s stock in a transaction on Wednesday, March 12th. The shares were sold at an average price of $109.98, for a total value of $1,216,378.80. Following the transaction, the executive vice president now directly owns 6,437 shares of the company’s stock, valued at approximately $707,941.26. This represents a 63.21 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Maynadier Patrick D. De sold 54,510 shares of the company’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $115.98, for a total transaction of $6,322,069.80. Following the completion of the transaction, the executive vice president now directly owns 10,497 shares in the company, valued at $1,217,442.06. This trade represents a 83.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 65,570 shares of company stock valued at $7,538,449 in the last three months. 2.00% of the stock is currently owned by company insiders.

Church & Dwight Price Performance

Shares of NYSE:CHD opened at $108.20 on Friday. Church & Dwight Co., Inc. has a one year low of $96.35 and a one year high of $116.46. The stock has a fifty day moving average of $107.31 and a 200-day moving average of $105.84. The company has a market capitalization of $26.61 billion, a PE ratio of 45.65, a price-to-earnings-growth ratio of 3.32 and a beta of 0.57. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.24 and a current ratio of 1.70.

Church & Dwight (NYSE:CHD) last announced its earnings results on Friday, January 31st. The company reported $0.77 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same quarter in the prior year, the company posted $0.65 EPS. As a group, equities analysts anticipate that Church & Dwight Co., Inc. will post 3.7 EPS for the current fiscal year.

Church & Dwight Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Friday, February 14th were paid a dividend of $0.295 per share. This is an increase from Church & Dwight’s previous quarterly dividend of $0.28. This represents a $1.18 annualized dividend and a yield of 1.09%. The ex-dividend date was Friday, February 14th. Church & Dwight’s payout ratio is 49.79%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Truist Financial boosted their price objective on Church & Dwight from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, February 3rd. Royal Bank of Canada reiterated a “sector perform” rating and set a $105.00 price objective on shares of Church & Dwight in a research report on Monday, February 3rd. JPMorgan Chase & Co. reduced their price objective on Church & Dwight from $107.00 to $106.00 and set an “underweight” rating for the company in a research report on Friday, February 21st. Piper Sandler reduced their price objective on Church & Dwight from $128.00 to $126.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Finally, Barclays boosted their price objective on Church & Dwight from $90.00 to $93.00 and gave the stock an “underweight” rating in a research report on Tuesday, February 4th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $111.56.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.